Dynabeads™ Mouse Pan T (Thy1.2)
Dynabeads™ Mouse Pan T (Thy1.2)
Invitrogen™

Dynabeads™ Mouse Pan T (Thy1.2)

Dynabeads™マウスpan T(Thy 1.2)は、脾臓やリンパ節などの組織消化物、全血、骨髄、単核細胞(MNC詳細を見る
製品番号(カタログ番号)数量
11443D5 mL
製品番号(カタログ番号) 11443D
価格(JPY)
-
見積もりを依頼する
数量:
5 mL
Dynabeads™マウスpan T(Thy 1.2)は、脾臓やリンパ節などの組織消化物、全血、骨髄、単核細胞(MNC)を含むあらゆるサンプルからマウスT細胞を直接単離または除去するための堅牢で汎用性の高いツールを提供する磁気ビーズです。
•任意のサンプルからマウスT細胞を迅速に単離 – カラムは不要
• 下流の分子アッセイ用のポジティブ単離、またはマウスT細胞の効率的な除去

回収細胞の優れた収率、純度、生存率を実現
Dynabeads™マウスpan T(Thy 1.2)は均一な(直径4.5 µmの)超常磁性ビーズで、脾臓またはリンパ節からマウスT細胞を容易に単離しますが、どの単一細胞懸濁液でも使用できます。Dynabeads™マウスpan Tビーズは、すべての一般的なマウス株の末梢T細胞、胸腺細胞、および上皮内Tリンパ球で発現される、Thy 1.2膜抗原に特異的な一次モノクローナル抗体でコーティングされています。Dynabeads™マウスpan Tは短いインキュベーション時間でT細胞とチューブ内で結合します。その後、マグネットを使用して、ビーズ結合細胞と未結合細胞を分離します。この単離方法は迅速かつ穏やかであり、カラムを使用する必要がありません。また、単離したT細胞の高い純度、回収率、生存率を実現します。

除去、下流の分子アッセイ用のポジティブ単離のどちらにも最適
分離には強力なマグネットを使用するため、Dynabeads™マウスpan T(Thy 1.2)は組織の単一細胞懸濁液、全血、骨髄などの粘性の高いサンプルにも使用でき、約30分でマウスT細胞を効率的に除去することが可能です。またDynabeads™マウスpan Tを下流の検討用のポジティブ単離に使用すると、高純度な生存細胞が優れた回収率で得られます。下流の検討の例としては、ビーズに付着したまま細胞を溶解し、核酸やタンパク質をさらに精製するものなどがあります。インタクト細胞はこれらのビーズから放出されないため、細胞ベースのアプリケーション用にマウスT細胞を単離する場合、またはフローサイトメトリーでサンプルをチェックする必要がある場合は、Dynabeads™ FlowCompマウスPan T(CD90.2)(ビーズフリー細胞用)を使用する必要があります。

マウスT細胞単離製品から、お客様に最適なものをお選びください。

研究用途にのみご使用ください。ヒトまたは動物の治療もしくは診断目的には使用できません。
研究用途にのみご使用ください。診断目的には使用できません。
仕様
細胞タイプT細胞(全集団)
単離技術分子アプリケーションのための除去、ポジティブ単離
セル数合計で約2x10^9個の細胞を処理可能
出力実行可能性≧95%
製品ラインDYNAL、Dynabeads
純度または品質グレード研究グレード
数量5 mL
反応性マウス
サンプルタイプリンパ節、血液、脾臓
出荷条件室温
出発物質セル番号1つの単離あたり1 x 10^7個の細胞
ターゲット種マウス
直径(メートル法)4.5 μm
製品タイプ抗体コーティングビーズ
Unit SizeEach
組成および保存条件
この製品には以下が含まれます:Thy1.2モノクローナル抗体でコーティングされた 5 mL Dynabeads™マウスPan T。Thy1.2抗原は、最も一般的に使用されるマウス株のマウス末梢T細胞、胸腺細胞、および上皮内Tリンパ球に発現します。
保存:2~8℃

よくあるご質問(FAQ)

My Dynabeads magnetic beads are not pelleting well with the magnet. Do you have any suggestions for me?

Please review the following possibilities for why your Dynabeads magnetic beads are not pelleting:

- The solution is too viscous.
- The beads have formed aggregates because of protein-protein interaction.

Try these suggestions: - Increase separation time (leave tub on magnet for 2-5 minutes)
- Add DNase I to the lysate (~0.01 mg/mL)
- Increase the Tween 20 concentration to ~0.05% of the binding and/or washing buffer.
- Add up to 20 mM beta-merecaptoethanol to the binding and/or wash buffers.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

I have a long double-stranded DNA fragment I would like to isolate. What product do you recommend?

For biotin-labeled DNA that is less than 1 kb, we recommend you use Dynabeads M270 Streptavidin (Cat. No. 65305) and MyOne C1 magnetic beads (Cat. No. 65001). We recommend our Dynabeads KilobaseBINDER Kit (Cat. No. 60101), which is designed to immobilize long (>1 kb) double-stranded DNA molecules. The KilobaseBINDER reagent consists of M-280 Streptavidin-coupled Dynabeads magnetic beads along with a patented immobilization activator in the binding solution to bind to long, biotinylated DNA molecules for isolation. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/immobilisation-of-long-biotinylated-dna-fragments.html) for more information in regards to long biotinylated DNA fragment isolation.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

Can I use Dynabeads magnetic beads to isolate single-stranded DNA templates?

Yes, Dynabeads magnetic beads can be used to isolate single-stranded DNA. Streptavidin Dynabeads magnetic beads can be used to target biotinylated DNA fragments, followed by denaturation of the double-stranded DNA and removal of the non-biotinylated strand. The streptavidin-coupled Dynabeads magnetic beads will not inhibit any enzymatic activity. This enables further handling and manipulation of the bead-bound DNA directly on the solid phase. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/preparing-single-stranded-dna-templates.html) for more information in regards to single-stranded DNA capture.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

What is the magnetic susceptibility for Dynabeads magnetic beads?

Magnetic susceptibility is a measure of how quickly the beads will migrate to the magnet. This will depend on the iron content and the character of the iron oxide. The magnetic susceptibility given for the Dynabeads magnetic beads is the mass susceptibility, given either as cgs units/g or m^3/kg (the latter being an SI unit). For ferri- and ferromagnetic substances, the magnetic mass susceptibility is dependent upon the magnetic field strength (H), as the magnetization of such substances is not a linear function of H but approaches a saturation value with increasing field. For that reason, the magnetic mass susceptibility of the Dynabeads magnetic beads is determined by a standardized procedure under fixed conditions. The magnetic mass susceptibility given in our catalog is thus the SI unit. Conversion from Gaussian (cgs, emu) units into SI units for magnetic mass susceptibility is achieved by multiplying the Gaussian factor (emu/g or cgs/g) by 4 pi x 10^-3. The resulting unit is also called the rationalized magnetic mass susceptibility, which should be distinguished from the (SI) dimensionless magnetic susceptibility unit. In general, magnetic mass susceptibility is a measure of the force (Fz) influencing an object positioned in a nonhomogenous magnetic field. The magnetic mass susceptibility of the Dynabeads magnetic beads is measured by weighing a sample, and then subjecting the sample to a magnetic field of known strength. The weight (F1) is then measured, and compared to the weight of the sample when the magnetic field is turned off (F0). The susceptibility is then calculated as K x 10^-3 = [(F1-F0) x m x 0.335 x 10^6], where K is the mass susceptibility of the sample of mass m. The susceptibility is then converted to SI units.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

How can I determine coupling efficiency of Dynabeads magnetic beads?

There are different methods to check binding of ligands to the beads, including optical density (OD) measurement, fluorescent labeling, and radioactive labeling.

For OD measurement, you would measure the OD of the ligand before immobilization to the beads and compare it with the ligand concentration that is left in the supernatant after coating. This gives a crude measurement of how much protein has bound to the beads.

Protocol:

1.Set spectrophotometer to the right wavelength. As a blank, use the Coupling Buffer.
2.Measure the absorbance of the Pre-Coupling Solution. A further dilution may be necessary to read the absorbance, depending upon the amount of ligand added.
3.Measure the absorbance of the Post-Coupling Solution. A dilution may be necessary to read the absorbance.
4.Calculate the coupling efficiency, expressed as the % protein uptake, as follows. [(Pre-Coupling Solution x D) - (Post-Coupling Solution x D)] x 100/(Pre-Coupling Solution x D) where D = dilution factor.

For fluorescent labeling, we suggest negatively quantifying the amount of ligand bound by measuring ligand remaining in the coupling supernatant (compared to the original sample), rather than directly measuring the ligands on the beads. Add labeled ligand to the beads, and measure how much ligand is left in the supernatant (not bound to the beads). By comparing this with the total amount added in the first place, you can then calculate how much of the ligand that has been bound to the beads. Keep in mind that the Dynabeads magnetic beads are also autofluorescent, which is why direct measuring of fluorescence of the bead-bound ligands is not recommended, but rather this indirect approach. The label could be, for example, FITC/PE. Some researchers perform a direct approach with success (using a flow cytometer).

Radioactive labeling is the most sensitive method of the three, but it is also the most difficult one. It involves radioactively labeling a portion of the ligand. We use radiolabeled I-125 in tracer amounts and mix it with "cold" ligands in a known ratio before coupling. The absolute quantities for the ligand on the beads should be obtained by measuring the beads in a scintillation (gamma) counter and comparing the cpm with a standard.

Protocol:

1.Take out an appropriate amount of beads and wash the beads in 1 mL of binding buffer.
2.Pipette out desired amount of human IgG in a separate tube.
3.Mix the human IgG with I-125-labeled human IgG (30,000 - 100,000 cpm).
4.Dilute the mixture of human IgG and I-125-labeled human IgG to 100 mL in binding buffer.
5.Incubate for 30 minutes at room temperature and measure the cpm in a scintillation counter.
6.Wash the beads (with coating) four times, and measure cpm again.
The % binding is calculated by using the equation : (cpm after washing/cpm before washing)x100%.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

引用および参考文献 (5)

引用および参考文献
Abstract
Myeloid C3 determines induction of humoral responses to peripheral herpes simplex virus infection.
Authors:Verschoor A, Brockman MA, Gadjeva M, Knipe DM, Carroll MC,
Journal:J Immunol
PubMed ID:14607939
'The complement system, in addition to its role in innate immunity, is an important regulator of the B cell response. Complement exists predominantly in the circulation and although the primary source is hepatic, multiple additional cellular sources have been described that can contribute substantially to the complement pool. To date, ... More
Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease.
Authors:Paust S, Lu L, McCarty N, Cantor H,
Journal:Proc Natl Acad Sci U S A
PubMed ID:15235129
'Although there is considerable evidence that a subpopulation of regulatory CD4(+)CD25+ T cells can suppress the response of autoreactive T cells, the underlying molecular mechanism is not understood. We find that transmission of a suppressive signal by CD4CD25+ regulatory cells requires engagement of the B7 molecule expressed on target T ... More
Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells.
Authors:Lazdina U, Cao T, Steinbergs J, Alheim M, Pumpens P, Peterson DL, Milich DR, Leroux-Roels G, Sällberg M,
Journal:J Virol
PubMed ID:11413303
'The nucleocapsid of the hepatitis B virus (HBV) is composed of 180 to 240 copies of the HBV core (HBc) protein. HBc antigen (HBcAg) capsids are extremely immunogenic and can activate naive B cells by cross-linking their surface receptors. The molecular basis for the interaction between HBcAg and naive B ... More
A sexual dimorphism in intrathymic sialylation survey is revealed by the trans-sialidase from Trypanosoma cruzi.
Authors:Mucci J, Mocetti E, Leguizamón MS, Campetella O,
Journal:J Immunol
PubMed ID:15814675
Sialylation is emerging as an important issue in developing thymocytes and is considered among the most significant cell surface modifications, although its physiologic relevance is far from being completely understood. It is regulated by the concerted expression of sialyl transferases along thymocyte development. After in vivo administration of trans-sialidase, a ... More
Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors.
Authors:Brody JD, Goldstein MJ, Czerwinski DK, Levy R,
Journal:Blood
PubMed ID:18812472
Ex vivo-expanded tumor-infiltrating lymphocytes infused into lymphodepleted recipients has clear antitumor efficacy. More practical sources of such antitumor lymphocytes would broaden the application of this approach. Previously, we described an in situ vaccination combining chemotherapy with intratumoral injection of CpG-enriched oligonucleotides, which induced T-cell immunity against established lymphoma. An ongoing ... More